The store will not work correctly when cookies are disabled.
ethyl 6-methyl-4-(phenylselanyl)quinoline-2-carboxylate
ID: ALA4633014
PubChem CID: 156010346
Max Phase: Preclinical
Molecular Formula: C19H17NO2Se
Molecular Weight: 370.31
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCOC(=O)c1cc([Se]c2ccccc2)c2cc(C)ccc2n1
Standard InChI: InChI=1S/C19H17NO2Se/c1-3-22-19(21)17-12-18(23-14-7-5-4-6-8-14)15-11-13(2)9-10-16(15)20-17/h4-12H,3H2,1-2H3
Standard InChI Key: NJUWYRGUOIUIOQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
15.3147 -23.4756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3136 -24.2952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0216 -24.7041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0198 -23.0668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7285 -23.4720 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7292 -24.2911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4378 -24.6981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1460 -24.2873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1413 -23.4652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4322 -23.0618 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.4394 -25.5153 0.0000 Se 0 0 0 0 0 2 0 0 0 0 0 0
18.1480 -25.9224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1464 -26.7373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8541 -27.1443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5619 -26.7342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5576 -25.9128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8493 -25.5094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8465 -23.0523 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6056 -24.7032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5567 -23.4566 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.8415 -22.2351 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.2619 -23.0437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9721 -23.4479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
7 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
9 18 1 0
2 19 1 0
18 20 1 0
18 21 2 0
20 22 1 0
22 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 370.31 | Molecular Weight (Monoisotopic): 371.0425 | AlogP: ┄ | #Rotatable Bonds: ┄ |
Polar Surface Area: ┄ | Molecular Species: ┄ | HBA: ┄ | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): ┄ | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: ┄ | CX LogD: ┄ |
Aromatic Rings: ┄ | Heavy Atoms: ┄ | QED Weighted: ┄ | Np Likeness Score: ┄ |
References
1. Costa CA, Lopes RM, Ferraz LS, Esteves GNN, Di Iorio JF, Souza AA, de Oliveira IM, Manarin F, Judice WAS, Stefani HA, Rodrigues T.. (2020) Cytotoxicity of 4-substituted quinoline derivatives: Anticancer and antileishmanial potential., 28 (11): [PMID:32336669] [10.1016/j.bmc.2020.115511] |